title: Bevacizumab in colorectal cancer: it should have worked.
authors.affiliation: GastroIntestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address: saltzl@mskcc.org.
authors.forename: Leonard B
authors.initials: LB
authors.lastname: Saltz
mesh_terms: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D000971:Antineoplastic Combined Chemotherapy Protocols; D000068258:Bevacizumab; D002166:Camptothecin; D003110:Colonic Neoplasms; D015179:Colorectal Neoplasms; D005472:Fluorouracil; D006801:Humans; D009944:Organoplatinum Compounds
chemical_list: D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D009944:Organoplatinum Compounds; D000068258:Bevacizumab; D005472:Fluorouracil; D002166:Camptothecin